Brief: Australia's ACCC Says It Will Not Oppose Revised Cochlear, Oticon Transaction
April 4 (Reuters) - Australian Competition and Consumer
Commission (ACCC):
* WILL NOT OPPOSE REVISED COCHLEAR, OTICON TRANSACTION
* CONSIDERS IT UNLIKELY THAT OTICON MEDICAL WOULD HAVE
BECOME A
STRONGER COMPETITOR IN SUPPLY OF COCHLEAR IMPLANTS IN
FORESEEABLE FUTURE
* SATISFIED THAT ITS COMPETITION CONCERNS WITH RESPECT TO
BONE
CONDUCTION SOLUTIONS ARE ADDRESSED
Further company coverage: COH.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cochlear
See all newsAustralia's Cochlear set for worst week in more than five months
Australia's Cochlear hit with shareholder lawsuit over 2026 earnings forecast (updated)
Australia's Cochlear falls after shareholder class action over FY2026 profit forecast
Cochlear to defend shareholder class action over 2026 profit forecast
Brief: Cochlear says class action claim filed against it in Supreme Court of Victoria